AS
ABMD

Altshuler Shaham’s Abiomed Inc ABMD Stock Holding History

Altshuler Shaham’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-135
Closed -$44K – 689
2021
Q3 		$44K Buy
+135
New +$45.7K ﹤0.01% 437
2021
Q1 		– Sell
-134
Closed -$43K – 555
2020
Q4 		$43K Sell
134
-150
-53% -$41.5K ﹤0.01% 282
2020
Q3 		$79K Buy
+284
New +$81.8K ﹤0.01% 197
2018
Q4 		– Sell
-18
Closed -$8K – 317
2018
Q3 		$8K Buy
+18
New +$7.1K ﹤0.01% 188

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Altshuler Shaham's ABMD Position: Q4 2021 in Review

Altshuler Shaham sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 135 shares — an estimated $44K sold.

Altshuler Shaham first reported a position in ABMD in Q3 2018 and held it in 4 quarters. The position peaked at $79K in Q3 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Altshuler Shaham reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Altshuler Shaham sold 135 Abiomed Inc shares in Q4 2021, an estimated $44K.
  • Altshuler Shaham first reported a position in Abiomed Inc in Q3 2018 and held it in 4 quarters.
  • Altshuler Shaham's Abiomed Inc position peaked at $79K in Q3 2020.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Altshuler Shaham's 13F filing for Q4 2021, filed 15 Feb 2022.